These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27401569)

  • 1. Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.
    Nankabirwa JI; Conrad MD; Legac J; Tukwasibwe S; Tumwebaze P; Wandera B; Brooker SJ; Staedke SG; Kamya MR; Nsobya SL; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5649-54. PubMed ID: 27401569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Uganda.
    Conrad MD; Mota D; Foster M; Tukwasibwe S; Legac J; Tumwebaze P; Whalen M; Kakuru A; Nayebare P; Wallender E; Havlir DV; Jagannathan P; Huang L; Aweeka F; Kamya MR; Dorsey G; Rosenthal PJ
    J Infect Dis; 2017 Nov; 216(8):1008-1017. PubMed ID: 28968782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Antimalarial Drug Sensitivities in Uganda.
    Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.
    Tumwebaze P; Conrad MD; Walakira A; LeClair N; Byaruhanga O; Nakazibwe C; Kozak B; Bloome J; Okiring J; Kakuru A; Bigira V; Kapisi J; Legac J; Gut J; Cooper RA; Kamya MR; Havlir DV; Dorsey G; Greenhouse B; Nsobya SL; Rosenthal PJ
    Antimicrob Agents Chemother; 2015; 59(6):3018-30. PubMed ID: 25753626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children.
    Conrad MD; LeClair N; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Tappero JW; Greenhouse B; Dorsey G; Rosenthal PJ
    J Infect Dis; 2014 Aug; 210(3):344-53. PubMed ID: 24610872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
    She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
    BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.
    Mwai L; Kiara SM; Abdirahman A; Pole L; Rippert A; Diriye A; Bull P; Marsh K; Borrmann S; Nzila A
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5069-73. PubMed ID: 19770282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda.
    Tukwasibwe S; Tumwebaze P; Conrad M; Arinaitwe E; Kamya MR; Dorsey G; Nsobya SL; Greenhouse B; Rosenthal PJ
    Malar J; 2017 Mar; 16(1):125. PubMed ID: 28327148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Aminoquinoline Resistance Genotypes and Clinical Presentations of Plasmodium falciparum Infection in Uganda.
    Cuu G; Asua V; Tukwasibwe S; Nsobya SL; Nanteza A; Kimuda MP; Mpimbaza A; Rosenthal PJ
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32660999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda.
    Nsobya SL; Dokomajilar C; Joloba M; Dorsey G; Rosenthal PJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3023-5. PubMed ID: 17562798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
    Yeka A; Wallender E; Mulebeke R; Kibuuka A; Kigozi R; Bosco A; Kyambadde P; Opigo J; Kalyesubula S; Senzoga J; Vinden J; Conrad M; Rosenthal PJ
    J Infect Dis; 2019 Mar; 219(7):1112-1120. PubMed ID: 30418593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between Malaria-Preventive Regimens and Plasmodium falciparum Drug Resistance-Mediating Polymorphisms in Ugandan Pregnant Women.
    Nayebare P; Asua V; Conrad MD; Kajubi R; Kakuru A; Nankabirwa JI; Muhanguzi D; Dorsey G; Kamya MR; Nsobya S; Rosenthal PJ
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELECTION OF PFCRT 76T AND PFMDR1 86Y MUTANT PLASMODIUM FALCIPARUM AFTER TREATMENT OF UNCOMPLICATED MALARIA WITH ARTESUNATE-AMODIAQUINE IN REPUBLIC OF GUINEA.
    Beavogui AH; Diawara EY; Cherif MS; Delamou A; Diallo N; Traore A; Millimouno P; Camara D; Sylla MM; Toure AA; Diallo MS; Toure S; Togo A; Camara G; Kourouma K; Sagara I; Dicko A; Djimde A
    J Parasitol; 2021 Sep; 107(5):778-782. PubMed ID: 34581793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.
    Asua V; Vinden J; Conrad MD; Legac J; Kigozi SP; Kamya MR; Dorsey G; Nsobya SL; Rosenthal PJ
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.
    Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE
    Malar J; 2015 Mar; 14():129. PubMed ID: 25890383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among almajirai in northeast Nigeria.
    Balogun ST; Sandabe UK; Bdliya DN; Adedeji WA; Okon KO; Fehintola FA
    J Infect Dev Ctries; 2015 Mar; 10(3):290-7. PubMed ID: 27031449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.